Improved Correlation of < sup > 18 < /sup > F-Flortaucipir PET SUVRs and Clinical Stages in the Alzheimer Disease Continuum with the MUBADA/PERSI-Based Analysis
Conclusion: MUBADA/PERSI provided the SUVR of 18F-flortaucipir uptake with better association with the clinical severity of the AD continuum and with smaller variability. The results support the usefulness of MUBADA/PERSI as a quantitative measure of 18F-flortaucipir uptake in multicenter studies using different PET systems and scanning methods. However, limitations of the study include the small sample size and the unbalanced distribution among clinical categories in the AMED Preclinical AD study database.PMID:38627012 | DOI:10.2967/jnmt.123.267113
Source: Journal of Nuclear Medicine Technology - Category: Nuclear Medicine Authors: Yasuhiko Ikari Go Akamatsu Keiichi Matsumoto Tomohiko Yamane Michio Senda Kazuki Fukuchi AMED Preclinical AD Study Investigators, and Alzheimer ’s Disease Neuroimaging Initiative Investigators Source Type: research
More News: Alzheimer's | Brain | Databases & Libraries | Neurology | Nuclear Medicine | Pathology | PET Scan | Statistics | Study